Skip to main content
OpenTrials
Completed

NCT Number: NCT01036243

Digestive Tolerance of Slightly Hydrolyzed Starter Infant Formula With Probiotics

To demonstrate that infants have improved gut comfort when fed a slightly hydrolyzed starter formula containing probiotics compared to infants fed a control hydrolyzed and referenced non-hydrolyzed formula.

Completed

Looking for future studies?

Notify Me

Key information

Age range

11 day–30 day

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chulalongkorn University

Bangkok, Thailand

About this study

Infants often experience undesirable gastrointestinal effects, such as constipation, flatulence. These symptoms are often perceived by the parents as being related to the diet (formula) the baby is consuming. In another hand, infantile colic or fussing/crying is one of the most commonly encountered problems within the first three months of life. The etiology of the disorder remains unknown however, three main theories have been proposed to explain its origin: (i) psychological: due to inadequate mother-infant interaction (ii) gastrointestinal: such as hypertonicity and immaturity of the GI tract and Dietary factors that may influence the stool pattern in formula fed infants are (iii) allergic: due to a reaction against cow's milk protein or other food constituents. e.g. the protein source, the iron content, hydrolyzation of the protein, or the fat source.

It has been reported that infants receiving a casein predominant formula had less unformed stools than those receiving a whey predominant formula. Hydrolysation of protein resulted in reduced gastro-intestinal transit time and some studies using extensively hydrolyzed protein formula have shown more liquid stools.

A reduction of crying hours was also described in infant receiving an hydrolyzed formula. Some probiotics were reported with potential benefit on the gut comfort.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy infants, 0-1 month old at point of enrollment
  • Birth weight < 2500g and > 4500g
  • Gestational age < 37 weeks and > 42 weeks
  • Infants who cannot be breastfed because of the maternal status
  • Willing to exclusively consume the assigned study formula with whey protein
  • Are likely to be compliant
  • Mother/caregiver demonstrates an understanding of the given information and ability to record the requested data

Exclusion criteria

  • Congenital illness or malformation
  • Significant pre-natal and/or post-natal disease
  • Receiving systemic antibiotic treatment at time of enrolment
  • Infant with symptoms of allergy to cow's milk
  • Infant's family cannot be expected to comply with treatment (feeding regimen)
  • Subjects who cannot be expected to comply with treatment
  • Currently participating or having participated in another clinical trial during the last month

Treatment and study plan

test formula 1

Dietary Supplement

hydrolyzed formula with probiotics

Other names: for 0-6 months as per standard requirement

test formula 2

Dietary Supplement

acidified hydrolyzed formula

Other names: suitable for 0-6 months as per standard requirement

test formula 3

Dietary Supplement

hydrolyzed formula without probiotics

Other names: suitable for 0-6 months of age as per standard requirement

reference formula

Dietary Supplement

standard infant formula

Other names: suitable for 0-6 months of age as per standard requirement

Primary outcomes

  1. incidence of crying/fussing from 1 to 3 months.

    Time frame: 3 months

Secondary outcomes

  1. growth and night sleep

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Société des Produits Nestlé (SPN)

Industry

Collaborators

  • Chulalongkorn University

Registry information

Official study title

Tolerance of a Slightly Hydrolyzed Starter Formula Containing Probiotics

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
Dec 21, 2009
Registry last updated
Jun 22, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.